Study Stopped
impossibility of continuing the study due to lack of medical staff
Oral Therapeutic Education in Stimulated Parkinsonian Patients
BUCCO-PARK
Exploratory Study of Oral Therapeutic Education in Stimulated Parkinsonian Patients: Monitoring of Periodontal Status and Microbiota
1 other identifier
interventional
15
1 country
1
Brief Summary
The effect of periodontal disease on the general condition of patients remains today underestimated in Parkinson's disease. The BUCCO-PARK project aims to carry out an exploratory study of oral therapeutic education on the clinical evolution and fate of the microbiota of patients undergoing brain stimulation surgery. During the study, patients will follow the standard care pathway alone or combined with an oral therapeutic education. Biological samples will assess how the microbiota of these patients will be impacted. BUCCO-PARK aims to optimize the care of Parkinson's patients by integrating oral care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Dec 2019
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2019
CompletedFirst Posted
Study publicly available on registry
May 29, 2019
CompletedStudy Start
First participant enrolled
December 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2023
CompletedJune 6, 2024
June 1, 2024
3.4 years
May 21, 2019
June 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Parodontal disease progression after 12 months
Parodontal disease progression according to criteria defined by CDC/AAP 6 months after surgery
12 months
Secondary Outcomes (21)
Parodontal disease progression after 6 months
6 months
Parodontal disease progression at inclusion
1 month
Caries index progression
12 months
Plaque index progression
12 months
Gingival index progression
12 months
- +16 more secondary outcomes
Study Arms (2)
Classical care pathway
NO INTERVENTIONPatients are following classical care pathway. Before brain surgery patients will be included after oral, medical and life quality evaluation. After randomization in the control group, patients will be evaluated at 6 and 12months after surgery, during classical follow up visits.
Oral education
EXPERIMENTALPatients are following classical care pathway but combined at each visit with an oral education Before brain surgery patients will be included after oral, medical and life quality evaluation. After randomization in the experimental group, patients will be evaluated at 6 and 12 months after surgery, during classical follow up visits. At each timepoint an oral education will be realized in parallel.
Interventions
Oral therapeutic education aims to improve dietary practices, daily hygiene and care, in an approach adapted to the characteristics and consequences of Parkinson's disease. An oral prevention package will be given to patients. Initially, dentists expose various oral health problems commonly found in Parkinson's disease, in order to give patients the necessary information for the understanding Secondly, dentists dispenseront practical advice tailored to pathology, to maintain good oral health
Eligibility Criteria
You may qualify if:
- Patients with idiopathic Parkinson's disease for whom deep brain stimulation surgery (indifferent target) has been indicated for their Parkinson's disease
- affiliated to a system of social security;
- having at least 10 natural teeth (treated or not)
- having received oral and written information on the protocol and having signed a consent to participate in this research.
You may not qualify if:
- pregnant or lactating women;
- Persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship), persons deprived of their liberty;
- Patients who do not speak French (both written and spoken);
- Patients whose oral status is considered incompatible by the dental surgeon investigator with entry into the study (history of major maxillofacial surgery, presence of drugs that may cause gingival hypertrophy 2 or gingival bleeding 3).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Rennes
Rennes, 35033, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc VERIN, Pr
Rennes University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2019
First Posted
May 29, 2019
Study Start
December 14, 2019
Primary Completion
May 19, 2023
Study Completion
May 19, 2023
Last Updated
June 6, 2024
Record last verified: 2024-06